Skin elasticity study aims to uncover side effects of Wilson's drug

NCT ID NCT06945081

Recruiting now Knowledge-focused Sponsor: Centre Hospitalier Universitaire de Saint Etienne Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study looks at skin damage caused by D-Penicillamine, a common treatment for Wilson's disease. Researchers will measure skin elasticity in 120 participants, including patients and healthy volunteers, using silicone molds and laser analysis. The goal is to better understand how the drug affects the skin over time.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: D-Penicillamine
What this could lead to: If successful, this could help doctors better understand and manage skin side effects from D-Penicillamine in Wilson's disease patients.
What could go wrong: This is an observational study, not a treatment trial. It only measures skin changes and does not test any new therapy or intervention.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for D-PENICILLAMINE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Wilson disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

D-PENICILLAMINE EFFECT OF D-PENICILLINE ON CUTANEOUS ELASTITY OF WILSON'S PATIENT WILSON DISEASE

Contacts and locations

Locations

Hospices Civils de Lyon
RECRUITING

Bron, 69677, France
Hôpital Nord CHU de Saint-Étienne
NOT_YET_RECRUITING

Saint-Etienne, 42055, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.